Biotech Investors & VC Firms in Europe
841 firms in this list, with a median first check of $500K. 192 of them lead rounds. Generated from verified public data and updated continuously.
EDB Investments
SingaporeSeed–Late Stage$12M – $400M
11 people
GRIDS Capital
São PauloSeed–Late Stage
3 people
Redstart Labs
IndiaPre-Seed–Series A
2 people
H.I.G. BioHealth Partners
Growth–Late Stage
6 people
Portal Innovations
ChicagoPre-Seed–Series A
AYANA Capital LLC
TampaPre-Seed–Series A$1M – $3M
2 people
Chemelot Ventures
Seed–Late Stage
6 people
GI Partners
San Francisco
3 people
Cathay Health
San FranciscoSeed–Late Stage
5 people
Cencora Ventures
San FranciscoSeed–Series B$1M – $10M
NGN Capital
New YorkSeries A–Late Stage
5 people
Atria Ventures
San FranciscoPre-Seed–Seed$500K – $3M
1 person
Medical Incubator Japan K.K.
TokyoSeries A–Series B
Syngenta Group Ventures
DurhamSeed–Growth$500K – $5M
6 people
Level Eight Ventures
Ann ArborSeed–Late Stage
4 people
Cancer Focus
HoustonPre-Seed–Series A
4 people
Chiesi Ventures
BostonSeed–Series A$5M
2 people
Grantham Foundation
BostonPre-Seed–Series A
2 people
Stake Capital
Pre-Seed–Series A
2 people
Robust
San FranciscoPre-Seed–Series B$1M – $2M
1 person
Earlymarket
Pre-Seed–Series A
Ferocity Capital
Palo Alto
3 people
SNR VC
SeattlePre-Seed–Series A
2 people
FAST — by GETTYLAB
San FranciscoPre-Seed–Seed$100K
1 person
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.












































